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Background: Patients who present with ST-Elevation Myocardial Infarction (STEMI) complicated by cardiogenic shock (CS) that suffer a cardiac 
arrest have high mortality rates. Little data exist on using Extracorporeal Membrane Oxygenation (ECMO) as a rescue device during CPR in the CS 
patient.
methods: We reviewed all patients from 8/2011 to 10/2012 who presented to a high volume, tertiary percutaneous coronary intervention (PCI) 
center, with STEMI complicated by CS that developed a PEA arrest during PCI and remained hemodynamically unstable despite mechanical CPR, 
IABP and inotropes. All patients were placed on percutaneous arterio-venous ECMO as a rescue device. All patients were intubated and all were 
hypoperfused with profound metabolic acidosis. Mechanical CPR via the LUCAS device was used in all patients. Median time of arrest from initiation 
of ECMO was 52 (range 16-133) minutes. Antegrade perfusion was established below the arterial ECMO sheath in all cases. ECMO was required for a 
median time of 4 (range 3-6) days.
results: The 5 patients included 2 females and 3 males with a median age of 64. Therapeutic hypothermia (TH) was instituted after initiation of 
ECMO in 4 (80%) of the cases. Ejection fractions of less than 10% were noted in 4 patients, and 1 patient had no cardiac output present prior to 
initiation of ECMO. Of 5 patients, 4 (80%) survived to hospital discharge and all of the survivors had good neurocognitive recovery (CPC 1 or 2) at 
discharge. Of the 4 survivors, discharge EF improved to a median of 45% (range 25-65%). Bleeding which required transfusion occurred in all cases.
conclusions: ECMO can be a lifesaving rescue technique when instituted by an experienced Shock Team in the CV lab for refractory PEA arrest 
occurring in the CV lab. Lucas CPR was a valuable adjunct. Striking recovery of LV function can also occur in several days. The combination of ECMO 
and TH was associated with excellent neurologic outcomes as well. ECMO may have a role in selected PCI centers with advanced specialized teams.
